Phoenix
  • About
  • Team
  • Strategic Partners
  • Advisors
  • Companies
  • Testimonials
  • News
  • Incubators
  • LP Portal
  • Contact
  • Facebook
  • Linkedin
Select Page

AbSci hopes to make E. Coli great again through engineered expression system

Feb 7, 2018 | Article, News, Show All

AbSci hopes to make E. Coli great again through engineered expression system

AbSci says its genetically engineered E. coli expression platform has produced yields exceeding 20 g/L for difficult to express products and threatens the dominance of mammalian systems.

Read the full article here: biopharma-reporter.com

Recent Posts

  • ReForm Biologics and KBI Biopharma Announce Strategic Partnership to Improve Biopharmaceutical Formulations and Development.
  • Group14 Technologies Q&A with Dr. John Chen
  • ReForm Biologics Secures New Patent Expanding Coverage of Key Excipient Formulation for Antibody-Based Therapeutics
  • AbSci hopes to make E. Coli great again through engineered expression system
  • AbSci Appoints Alan Herman, PhD to Scientific Advisory Board

Archives

  • ► 2018
    • April
    • March
    • February
  • ► 2017
    • December
    • November
    • October
    • July
    • June
    • May
    • March
    • February
    • January
  • ► 2016
    • October
    • September
    • August
    • May
    • April
  • ► 2015
    • October
    • August
  • ► 2013
    • September
  • ► 2012
    • October
    • April
    • March
    • February
    • January

Categories

  • Article
  • Interview
  • News
  • Press Release
  • Show All